MDB Capital Holdings, LLC reported a net loss of $21.3 million for the fiscal year ending December 31, 2025, a significant decline from a net income of $11.7 million in the previous year. The company's total operating income increased to $4.9 million from $2.2 million, primarily driven by a rise in fee income from investment banking activities, which surged to $4.3 million compared to $2.2 million in 2024. However, the overall financial performance was adversely affected by unrealized losses on investment securities and increased operational costs, leading to a net operating loss of $17.7 million, an improvement from the $28.6 million loss reported in 2024.
The company experienced notable changes in its operational structure, particularly with the deconsolidation of eXoZymes, which completed its initial public offering in November 2024. This transition reduced MDB's ownership stake from approximately 60% to 47%, resulting in a gain of $39.3 million recognized at the time of deconsolidation. The impact of this change was reflected in the financial statements, as eXoZymes is now accounted for under the equity method, contributing to a loss of $4.3 million for the year.
MDB's strategic developments included the launch of self-clearing operations by its subsidiary, Public Ventures, in January 2024, which is expected to enhance its operational capabilities. The company also entered into a Patent and Know-How License Agreement with the Mayo Foundation for Medical Education and Research for its partner company, MDB Minnesota One, aimed at developing a small molecule anti-senescence platform. This agreement is pivotal for M1's growth, as it holds exclusive rights to develop and commercialize Mayo's patented technology.
Operationally, MDB reported a decrease in employee headcount, with 14 full-time employees and 40 contractors as of the end of 2025. The company anticipates growth in personnel as it expands its operations and develops new partner companies. The overall working capital decreased to $13.2 million from $19.8 million, primarily due to expenditures related to operational activities. MDB's liquidity position remains stable, with cash reserves of $15.5 million, although $2.3 million is segregated for regulatory compliance.
Looking ahead, MDB Capital Holdings aims to leverage its public venture capital model to identify and develop early-stage companies, focusing on technology and life sciences sectors. The company plans to continue its investment strategy while navigating the complexities of regulatory compliance and market conditions. MDB's management remains optimistic about future growth opportunities, contingent on successful execution of its strategic initiatives and the performance of its partner companies.
About MDB Capital Holdings, LLC
MDB Capital Holdings is a platform that finances and develops early-stage technology companies through its subsidiaries. It acts as a founder, investor, and strategic partner, focusing on disruptive innovations with large market potential and strong IP. The company supports partner firms from inception to public markets, leveraging long-term community investors, intellectual property expertise, and a unique public venture capital model to foster industry leaders.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.